Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies

Erfan Abdollahizad, Anna Meyfour

Open source

DOI
10.1016/j.ctarc.2026.101301
Published
2026
Container
Cancer Treatment and Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101301,
  title = {Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies},
  author = {Erfan Abdollahizad and Anna Meyfour},
  year = {2026},
  journal = {Cancer Treatment and Research Communications},
  doi = {10.1016/j.ctarc.2026.101301},
  url = {https://doi.org/10.1016/j.ctarc.2026.101301}
}

RIS

TY  - JOUR
TI  - Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies
AU  - Erfan Abdollahizad
AU  - Anna Meyfour
PY  - 2026
JO  - Cancer Treatment and Research Communications
DO  - 10.1016/j.ctarc.2026.101301
UR  - https://doi.org/10.1016/j.ctarc.2026.101301
ER  - 

APA

Abdollahizad, E., & Meyfour, A. (2026). Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101301

Source records